Ellen Shrader
Impact in
-
- Ophthalmology and Eye Disorders
- Lymphoma Diagnosis and Treatment
-
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Papers in
-
- Histone Deacetylase Inhibitors Research 8
- Protein Degradation and Inhibitors 7
- Ubiquitin and proteasome pathways 2
-
- Multiple Myeloma Research and Treatments 5
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Nathan S. Schlezinger (1 shared paper)Mary Beth Tombes (19 shared papers)Steven Grant (14 shared papers)Maciej Kmieciak (16 shared papers)Beata Holkova (13 shared papers)John D. Roberts (12 shared papers)Heidi Sankala (12 shared papers)Danielle Shafer (5 shared papers)
- Journals
- Blood (8 papers)Clinical Cancer Research (2 papers)Journal of Clinical Oncology (2 papers)Neuro-Oncology Advances (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- United States
In The Last Decade
Ellen Shrader
20 papers receiving 261 citations
Peers
Comparison fields: 5 of 45
- Pathology and Forensic Medicine 94
- Hematology 48
- Genetics 30
- Neurology 41
- Oncology 56
Countries citing papers authored by Ellen Shrader
This map shows the geographic impact of Ellen Shrader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Shrader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Shrader more than expected).
Fields of papers citing papers by Ellen Shrader
This network shows the impact of papers produced by Ellen Shrader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Shrader. The network helps show where Ellen Shrader may publish in the future.
Co-authors
The 25 scholars most cited alongside Ellen Shrader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1960 | 67 | |
| 2 | 2011 | 39 | |
| 3 | 2013 | 31 | |
| 4 | 2017 | 21 | |
| 5 | 2015 | 18 | |
| 6 | 2020 | 16 | |
| 7 | 2023 | 14 | |
| 8 | 2020 | 11 | |
| 9 | 2011 | 9 | |
| 10 | 2014 | 9 | |
| 11 | 2016 | 8 | |
| 12 | 2012 | 7 | |
| 13 | 2013 | 5 | |
| 14 | 2012 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2011 | 3 | |
| 17 | 2012 | 2 | |
| 18 | 2011 | 2 | |
| 19 | 2017 | 2 | |
| 20 | 2024 | 2 |
About Ellen Shrader
Ellen Shrader is a scholar working on Molecular Biology, Hematology, Genetics, Oncology and Pathology and Forensic Medicine, having authored 20 papers that have together received 275 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (7 papers), Multiple Myeloma Research and Treatments (5 papers), Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (2 papers), Ubiquitin and proteasome pathways (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (94 citations), Hematology (48 citations), Genetics (30 citations), Neurology (41 citations) and Oncology (56 citations). Ellen Shrader has collaborated with scholars based in United States. Frequent co-authors include Nathan S. Schlezinger, Mary Beth Tombes, Steven Grant, Maciej Kmieciak, Beata Holkova, John D. Roberts, Heidi Sankala, Danielle Shafer, Prithviraj Bose and Wen Wan. Their work appears in journals such as Blood, Clinical Cancer Research, Journal of Clinical Oncology, Neuro-Oncology Advances and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.